Skip to content
DiviCompasshome

Stock research

Dbv Technologies SA (DBV) dividends

DBV on Euronext Paris, ISIN FR0010417345, Health Care

€1.75 -2.94% on previous close. Close on 18 Nov 2026, in EUR

Sign in to get an email when it declares a dividend.

Trailing yield—Regular dividends, last 12 months
Forward yield (estimate)—No estimate
Next 12 months per share—Irregular
5-year dividend growth—Not enough history
Payout ratio—Year to 31 Dec 2025
Free cash flow cover—Health score needs more data

Dbv Technologies SA dividend: key facts

Next dividend None expected In the next 12 months
How often Irregular No regular pattern
Market cap€412m
Shares in issue235.7m
Listed onEuronext Paris

Own Dbv Technologies SA? See exactly what it will pay you

Add your shares to a free DiviCompass portfolio to see your next DBV dividend in your own money, every payment month by month, and an email when it declares. Free for up to 10 holdings, no card needed.

Price history

End-of-day closes on Euronext Paris in EUR. Dots mark ex-dividend dates.

Dividend history

Declared dividends. Special dividends are marked and excluded from yield and forecasts.

No dividends imported for this company.It may not pay a dividend, or its dividends have not been added yet.

Reported financials

Annual figures from filings, converted to units.

Year toRevenueNet incomeEPSFree cash flowSource
31 Dec 2025IFRS EUR — -€147.2m -€1.05 — Source (opens in a new tab)
31 Dec 2024IFRS EUR €0 -€114.1m -€1.18 — Source (opens in a new tab)
31 Dec 2023IFRS EUR €0 -€72.7m -€0.76 -€78.3mDerived Source (opens in a new tab)

About Dbv Technologies SA

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

From Wikipedia, CC BY-SA 4.0.

Next 12 months

No dividends expected from the data available.

Estimate confidence: None

Company news

Insufficient verified data for a financial-health score

Dividend data and price last updated 18 Nov 2026.